Living Tumor Laboratory

Living Tumor Laboratory is a Vancouver-based oncology-focused organization built around patient-derived xenograft and related living tumor model systems for translational cancer research and preclinical drug evaluation. The group is best known for establishing high-fidelity patient-derived cancer tissue models using subrenal capsule grafting, with a particularly strong track record in prostate cancer and other solid tumors. Its platform is used to evaluate anti-cancer therapeutics, study treatment resistance and tumor dormancy, identify biomarkers and therapeutic targets, and support evidence-based personalized cancer therapy research. Living Tumor Laboratory appears to operate more as a specialized translational oncology and preclinical services organization than as a traditional clinical-stage drug developer. Public evidence does not show a conventional named therapeutic pipeline advancing through human clinical trials.